BridgeMD
Tests treatment safety and results for Chronic Leg Ulcer
Official title Efficacy of Platelet-rich-Fibrin Gel in Patients With Chronic Leg Ulcers
ClinicalTrials.gov ID: NCT07294521
What this study is testing
What is Platelet rich Fibrin (PRF)?
Platelet rich Fibrin (PRF) is an investigational medicine, given as a treatment applied to the skin, being studied as a potential treatment for chronic leg ulcer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Platelet rich Fibrin (PRF) gel is an emerging as a novel treatment option for chronic leg ulcers and has the potential to become the 1st line option in these conditions. The objective of our study will be to assess the efficacy of PRF gel dressing in patients with non-infective chronic leg ulcers.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 and older. Healthy volunteers may be eligible.
You may be able to join if
- All male and female patients more than 35 years old with Chronic Leg Ulcers, presenting to the OPD will be included.
You likely can't join if
- Patients with clinical signs of infected ulcers, patients in sepsis and immunosuppressed individuals will be excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Rawalpindi, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rawalpindi, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.